GSA CAPITAL PARTNERS LLP - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 190 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$744,000
+148.0%
106,172
+193.0%
0.11%
+180.0%
Q1 2022$300,000
+85.2%
36,241
+51.5%
0.04%
+100.0%
Q4 2021$162,000
+18.2%
23,928
+0.3%
0.02%
+33.3%
Q2 2021$137,000
-67.3%
23,855
-73.8%
0.02%
-78.6%
Q1 2021$419,000
+24.7%
90,890
-9.7%
0.07%
+27.3%
Q4 2020$336,000
+1.8%
100,605
+17.4%
0.06%
-33.7%
Q1 2020$330,000
-53.1%
85,680
-54.3%
0.08%
+1.2%
Q4 2019$703,000
+282.1%
187,496
+441.3%
0.08%
+228.0%
Q3 2019$184,000
+82.2%
34,638
+32.1%
0.02%
+127.3%
Q2 2019$101,000
-86.8%
26,220
-87.1%
0.01%
-73.8%
Q3 2018$767,000
-35.4%
202,845
-46.7%
0.04%
-28.8%
Q2 2018$1,187,000
+416.1%
380,605
+295.7%
0.06%
+391.7%
Q1 2018$230,000
-81.0%
96,196
-79.9%
0.01%
-85.4%
Q3 2017$1,208,000
+48.8%
479,196
-35.7%
0.08%
+86.4%
Q3 2016$812,000
+84.5%
745,077
+20.2%
0.04%
+83.3%
Q2 2016$440,000619,7770.02%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 208,189$1,726,0003.48%
FRIESS ASSOCIATES LLC 571,940$4,741,0002.53%
GABLES CAPITAL MANAGEMENT INC. 438,764$3,637,0002.28%
Prairiewood Capital, LLC 258,073$2,139,0001.50%
Quantedge Capital Pte Ltd 597,300$4,952,0001.46%
ARMISTICE CAPITAL, LLC 8,372,000$69,404,0001.34%
SummerHaven Investment Management, LLC 158,473$1,314,0000.74%
Capital Impact Advisors, LLC 99,322$823,0000.60%
EAM Investors, LLC 365,415$3,029,0000.56%
GLOBEFLEX CAPITAL L P 304,515$2,524,0000.51%
View complete list of CATALYST PHARMACEUTICALS INC shareholders